Literature DB >> 33082508

What can we learn from PWS and SNORD116 genes about the pathophysiology of addictive disorders?

Juliette Salles1,2,3,4, Emmanuelle Lacassagne3, Sanaa Eddiry3, Nicolas Franchitto1,5, Jean-Pierre Salles3, Maithé Tauber6,7,8,9.   

Abstract

Addictive disorders have been much investigated and many studies have underlined the role of environmental factors such as social interaction in the vulnerability to and maintenance of addictive behaviors. Research on addiction pathophysiology now suggests that certain behavioral disorders are addictive, one example being food addiction. Yet, despite the growing body of knowledge on addiction, it is still unknown why only some of the individuals exposed to a drug become addicted to it. This observation has prompted the consideration of genetic heritage, neurodevelopmental trajectories, and gene-environment interactions in addiction vulnerability. Prader-Willi syndrome (PWS) is a rare neurodevelopmental disorder in which children become addicted to food and show early social impairment. PWS is caused by the deficiency of imprinted genes located on the 15q11-q13 chromosome. Among them, the SNORD116 gene was identified as the minimal gene responsible for the PWS phenotype. Several studies have also indicated the role of the Snord116 gene in animal and cellular models to explain PWS pathophysiology and phenotype (including social impairment and food addiction). We thus present here the evidence suggesting the potential involvement of the SNORD116 gene in addictive disorders.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33082508     DOI: 10.1038/s41380-020-00917-x

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  84 in total

1.  The descriptive features of food addiction; addictive eating and drinking.

Authors:  T G RANDOLPH
Journal:  Q J Stud Alcohol       Date:  1956-06

Review 2.  Should addictive disorders include non-substance-related conditions?

Authors:  Marc N Potenza
Journal:  Addiction       Date:  2006-09       Impact factor: 6.526

3.  Requirement of central ghrelin signaling for alcohol reward.

Authors:  Elisabet Jerlhag; Emil Egecioglu; Sara Landgren; Nicolas Salomé; Markus Heilig; Diederik Moechars; Rakesh Datta; Daniel Perrissoud; Suzanne L Dickson; Jörgen A Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

Review 4.  Neurobiology of addiction: a neurocircuitry analysis.

Authors:  George F Koob; Nora D Volkow
Journal:  Lancet Psychiatry       Date:  2016-08       Impact factor: 27.083

5.  Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice.

Authors:  Elisabet Jerlhag; Jörgen A Engel
Journal:  Drug Alcohol Depend       Date:  2011-02-09       Impact factor: 4.492

6.  Animal models of sugar and fat bingeing: relationship to food addiction and increased body weight.

Authors:  Nicole M Avena; Miriam E Bocarsly; Bartley G Hoebel
Journal:  Methods Mol Biol       Date:  2012

7.  Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving.

Authors:  Lorenzo Leggio; Anna Ferrulli; Silvia Cardone; Antonio Nesci; Antonio Miceli; Noemi Malandrino; Esmeralda Capristo; Benedetta Canestrelli; Palmiero Monteleone; George A Kenna; Robert M Swift; Giovanni Addolorato
Journal:  Addict Biol       Date:  2011-03-11       Impact factor: 4.280

8.  Systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine.

Authors:  Elisabet Jerlhag
Journal:  Addict Biol       Date:  2008-09       Impact factor: 4.280

9.  Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence.

Authors:  Carlo Colantuoni; Pedro Rada; Joseph McCarthy; Caroline Patten; Nicole M Avena; Andrew Chadeayne; Bartley G Hoebel
Journal:  Obes Res       Date:  2002-06

10.  Oxytocin functions as a spatiotemporal filter for excitatory synaptic inputs to VTA dopamine neurons.

Authors:  Lei Xiao; Michael F Priest; Yevgenia Kozorovitskiy
Journal:  Elife       Date:  2018-04-20       Impact factor: 8.140

View more
  6 in total

1.  Impact of Deprivation on Obesity in Children with PWS.

Authors:  Sabrina Grolleau; Marine Delagrange; Melina Souquiere; Catherine Molinas; Gwenaëlle Diene; Marion Valette; Maithé Tauber
Journal:  J Clin Med       Date:  2022-04-18       Impact factor: 4.964

2.  A report on seven fetal cases associated with 15q11-q13 microdeletion and microduplication.

Authors:  Xiuzhu Huang; Jieping Chen; Wenlong Hu; Lu Li; Huiyan He; Hui Guo; Qiuyan Liao; Mei Ye; Donge Tang; Yong Dai
Journal:  Mol Genet Genomic Med       Date:  2021-02-04       Impact factor: 2.183

Review 3.  Epigenetics in Prader-Willi Syndrome.

Authors:  Aron Judd P Mendiola; Janine M LaSalle
Journal:  Front Genet       Date:  2021-02-15       Impact factor: 4.599

Review 4.  Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium.

Authors:  Lauren Schwartz; Assumpta Caixàs; Anastasia Dimitropoulos; Elisabeth Dykens; Jessica Duis; Stewart Einfeld; Louise Gallagher; Anthony Holland; Lauren Rice; Elizabeth Roof; Parisa Salehi; Theresa Strong; Bonnie Taylor; Kate Woodcock
Journal:  J Neurodev Disord       Date:  2021-06-21       Impact factor: 4.025

5.  Patients with PWS and related syndromes display differentially methylated regions involved in neurodevelopmental and nutritional trajectory.

Authors:  Juliette Salles; Sanaa Eddiry; Emmanuelle Lacassagne; Virginie Laurier; Catherine Molinas; Éric Bieth; Nicolas Franchitto; Jean-Pierre Salles; Maithé Tauber
Journal:  Clin Epigenetics       Date:  2021-08-13       Impact factor: 6.551

6.  SNORD116 and growth hormone therapy impact IGFBP7 in Prader-Willi syndrome.

Authors:  Sanaa Eddiry; Gwenaelle Diene; Catherine Molinas; Juliette Salles; Françoise Conte Auriol; Isabelle Gennero; Eric Bieth; Boris V Skryabin; Timofey S Rozhdestvensky; Lisa C Burnett; Rudolph L Leibel; Maithé Tauber; Jean Pierre Salles
Journal:  Genet Med       Date:  2021-05-26       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.